SIGNIFICANT ACCOUNTING POLICIES (Tables) |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
SIGNIFICANT ACCOUNTING POLICIES (Tables) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of net sales |
The following table presents our net sales by product category for the year ended December 31, 2019 and 2018:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in deferred revenue |
The following table presents the changes in deferred revenue, reflected as current and long term liabilities on the Company's consolidated balance sheet:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of computations of weighted average shares outstanding |
|